Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R R Bandekar

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Community Dentistry and Oral Epidemiology|March 23, 1999
Fluoride supplements and fluorosis: a meta-analysisA I Ismail, R R Bandekar
Alimentary Pharmacology & Therapeutics|January 3, 2001
Helicobacter pylori screening for individuals requiring chronic NSAID therapy: a decision analysisJ M Scheiman, R R Bandekar, M E Chernew, et al.
Archives of Internal Medicine|December 9, 2000
Potential clinical and economic effects of homocyst(e)ine loweringB K Nallamothu, A M Fendrick, M Rubenfire, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 23, 2009
Randomized, double-blind, dose-ranging trial of the oral neurokinin-1 receptor antagonist casopitant mesylate for the prevention of cisplatin-induced nausea and vomitingF Roila, J Rolski, R Ramlau, et al.
Archives of Internal Medicine|February 2, 1999
Clinical and economic effects of population-based Helicobacter pylori screening to prevent gastric cancerA M Fendrick, M E Chernew, R A Hirth, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Community Dentistry and Oral Epidemiology|March 23, 1999
Fluoride supplements and fluorosis: a meta-analysisA I Ismail, R R Bandekar
Alimentary Pharmacology & Therapeutics|January 3, 2001
Helicobacter pylori screening for individuals requiring chronic NSAID therapy: a decision analysisJ M Scheiman, R R Bandekar, M E Chernew, et al.
Archives of Internal Medicine|December 9, 2000
Potential clinical and economic effects of homocyst(e)ine loweringB K Nallamothu, A M Fendrick, M Rubenfire, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 23, 2009
Randomized, double-blind, dose-ranging trial of the oral neurokinin-1 receptor antagonist casopitant mesylate for the prevention of cisplatin-induced nausea and vomitingF Roila, J Rolski, R Ramlau, et al.
Archives of Internal Medicine|February 2, 1999
Clinical and economic effects of population-based Helicobacter pylori screening to prevent gastric cancerA M Fendrick, M E Chernew, R A Hirth, et al.
Pageof 1